PureCycle shares fell approximately 12% after the Company disclosed that two operational reliability issues at its Ironton plant constrained third-quarter production, leaving it without sufficient inventory to meet internal revenue targets. Investors who lost money may be entitled to seek a recovery.

NEW YORK, Nov. 5, 2026 /PRNewswire/ — On November 4, 2026, PureCycle Technologies, Inc. (NASDAQ: PCT) shares fell approximately 10.6% during the November 4, 2026 trading session. After market close, the Company disclosed in its third-quarter report that two reliability issues at its Ironton plant had limited production during the quarter. Investors who suffered losses are encouraged to report their PCT losses now. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com or by telephone at (888) SueWallSt.

Third-quarter revenue was $2.349 million, down from $4.5 million in the second quarter. That is a drop of nearly 48% in three months. Purified production at Ironton for the quarter ended September 30, 2026 totaled 5.2 million pounds.

PureCycle’s third-quarter revenue fell to $2.3 million from $4.5 million in the second quarter, a nearly 48% sequential decline. Although Ironton produced 5.2 million pounds of PureFive® resin, management acknowledged that two reliability issues had constrained production and that New Jersey’s extension of its food-contact exemption delayed approximately 15 customer programs, representing roughly 50 million pounds of expected annual volume at full ramp. Management admitted these operational issues and regulatory delays caused the quarter to fall short of plan. SueWallSt  is investigating whether PureCycle adequately disclosed its dependence on New Jersey’s regulatory timeline and the extent to which the anticipated 2026 commercial ramp depended on food-contact approvals.

If you purchased PureCycle shares and suffered a loss, start your free PCT loss review or call Joseph E. Levi, Esq. at (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the PCT Investigation

Q: Who is eligible to participate in the PCT investigation?A: Investors who purchased PCT stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: How much did PCT stock drop?A: PureCycle shares fell approximately 10.6% on November 4, 2026, closing at $2.79, down from $3.12. After the market closed, the Company disclosed that two reliability issues at its Ironton plant had constrained third-quarter production and contributed to its failure to meet internal revenue goals. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.

Q: What do PCT investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What is a lead plaintiff and why does it matter?A: If the investigation proceeds to legal action, a lead plaintiff is the investor the court appoints to represent the group of affected investors. Lead plaintiffs are typically investors with the largest documented losses. Contacting the firm during the investigation phase preserves that option.

Q: What if I already sold my PCT shares — can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought PCT and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/purecycle-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-purecycle-pct-302931388.html

SOURCE Levi & Korsinsky, LLP